NOXXON Pharma N.V announced the appointment of two leading brain cancer experts to its Scientific Advisory Board. Prof. Monika Hegi and Dr. Michael Lim and will complement the current SAB and provide strategic and scientific counsel to NOXXON's lead NOX-A12 program in brain cancer (glioblastoma). Monika E. Hegi is the Head of Laboratory of Brain Tumor Biology and Genetics, Department of Clinical Neurosciences, University Hospital Lausanne, Switzerland.

Michael Lim is the Professor and Chair of the Department of Neurosurgery, Stanford University, California, USA.